tada, I agree with you and Mazola.

In order meet financial commitments for the future including the LOC the agreement must provide $100 million USD at least. Would this not be the single biggest commitment to date? If successful it certainly fulfills a major barrier...the LOC and potential loss of IP to KD.

Having been very optimistic a few years ago feeling AZ would just jump in because of the Crestor + apabetalone results so I must take a more sopber approach.

However, perhaps we are at the point of serious interest based on the post hocs, 4 +ve DSMB reports, perhaps a sense that FA will be positive, positive findings by independent scientists, FDA approval of BoM, RVX's 8 year lead in CVD epigenetic research, orphan trial potential, the CKD trial, etc.

It could be to the point where RVX finally has achieved some scientific credibility.

GLTA

Toinv